FDA emergency use authorization doubles expected allocation.
The Department of Health and Human Services (HHS) announced this week that it will be providing states with up to 442,000 vaccines to address America’s monkeypox outbreak. This is double the amount of doses the government initially estimated it would be providing. The Food and Drug Administration’s (FDA) ruling to allow intradermal injections makes smaller doses of the vaccine more effective, enabling the government’s stockpile of vaccines to spread much further to combat the virus.
“FDA’s emergency use authorization of intradermal injection of the JYNNEOS vaccine is allowing us to get more doses to jurisdictions faster than anticipated and will help end this national monkeypox outbreak,” HHS Secretary Xavier Becerra said.
As the Lord Leads, Pray with Us…
- For Commissioner Califf as he oversees reviews and authorizations of therapies and medications at the FDA.
- For Secretary Becerra to seek the Lord’s wisdom as he heads the federal health department.
- For HHS and FDA officials as they work together to protect public health.
Sources: The Hill, Reuters
